BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Solve ME/CFS Initiative - ECPv6.15.17//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Solve ME/CFS Initiative
X-ORIGINAL-URL:https://solvecfs.org
X-WR-CALDESC:Events for Solve ME/CFS Initiative
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Shanghai
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:CST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Krasnoyarsk
BEGIN:STANDARD
TZOFFSETFROM:+0700
TZOFFSETTO:+0700
TZNAME:+07
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220504T100000
DTEND;TZID=America/Los_Angeles:20220504T110000
DTSTAMP:20260802T090419
CREATED:20220413T204106Z
LAST-MODIFIED:20220425T201500Z
UID:34533-1651658400-1651662000@solvecfs.org
SUMMARY:Remote Congressional Meeting Training
DESCRIPTION:Join the Solve M.E. Advocacy team for a training session outlining best practices for your congressional meetings! \nRegister here.
URL:https://solvecfs.org/event/remote-congressional-meeting-training/
LOCATION:Online
CATEGORIES:Advocacy Month 2022
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2022/04/Remote-Congressional-Meeting-Training.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220502T100000
DTEND;TZID=America/Los_Angeles:20220502T110000
DTSTAMP:20260802T090419
CREATED:20220118T002046Z
LAST-MODIFIED:20220426T002535Z
UID:32691-1651485600-1651489200@solvecfs.org
SUMMARY:Advocacy Month Kickoff
DESCRIPTION:We are kicking off Advocacy Month with a keynote address by disability advocate Jessica Kellgren-Fozard and a discussion about the importance of sharing our stories and raising our voices to create change! \nRegister here.
URL:https://solvecfs.org/event/advocacy-month-kickoff/
LOCATION:Online
CATEGORIES:Advocacy Month 2022
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2022/01/Advo-Kickoff-IGFB.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20220421T100000
DTEND;TZID=Asia/Shanghai:20220421T110000
DTSTAMP:20260802T090419
CREATED:20220414T161402Z
LAST-MODIFIED:20220414T221551Z
UID:34561-1650535200-1650538800@solvecfs.org
SUMMARY:CDMRP for ME/CFS: Navigating the Grant Application Process
DESCRIPTION:The FY22 Defense Appropriation provides funding to support therapeutic research related to medical threats\, and treatments for Service Members in current and future battlefield settings. The managing agent for the funding opportunities is the Department of Defense Office of Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC). One of the Focus Areas for funding in FY22 is myalgic encephalomyelitis/chronic fatigue syndrome. Last year\, ME/CFS researchers received $2.5 million in funding from the Peer-Reviewed Medical Research Program. \nThis informational webinar is designed to better inform and prepare the ME/CFS research community about the Peer Reviewed Medical Research Program (PRMRP) and the grant application process.  Panelists include Cecilia Dupecher\, PhD (Program Manager for PRMRP at the Congressionally Directed Medical Research Programs – CDMRP) and Solve M.E.’s Oved Amitay\, Emily Taylor\, and Leslie Phillips. \nIf you have questions for our panelists\, please send them to SolveCFS@solvecfs.org.
URL:https://solvecfs.org/event/cdmrp-for-me-cfs-navigating-the-grant-application-process/
CATEGORIES:Research,Solve M.E. Leadership,Webinar
ATTACH;FMTTYPE=image/jpeg:https://solvecfs.org/wp-content/uploads/2022/04/CDMRPTwitter.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Krasnoyarsk:20220412T130000
DTEND;TZID=Asia/Krasnoyarsk:20220412T140000
DTSTAMP:20260802T090419
CREATED:20220309T205636Z
LAST-MODIFIED:20220401T222237Z
UID:33569-1649768400-1649772000@solvecfs.org
SUMMARY:Long Covid: Research\, Policy and Economic Impact (Session II)
DESCRIPTION:Solve Long Covid Initiative\, in partnership with the Global Interdependence Center\, is conducting a year-long webinar and conference series exploring the pandemic’s long-term healthcare\, policy\, and economic impact\, specifically the implications of long haul COVID or long COVID. \nThis program\, in partnership with the Solve Long Covid Initiative\, will feature speakers Katie Bach\, a Nonresident Senior Fellow at Brookings\, and Melissa Smallwood\, a Graduate Student Researcher\, College of Global Futures. Our speakers will participate in a live audience Q&A moderated by Emily Taylor\, Vice President of Advocacy and Community Engagement at Solve M.E. \nOver the next twelve months\, GIC and SLCI will bring together world-class immunologists\, medical experts\, policymakers\, and economists to explore critical insights into defining\, diagnosing\, optimizing treatments\, and healthcare policies for long COVID and analyzing its impact on U.S. and global labor markets. \nLearn more and register here.
URL:https://solvecfs.org/event/long-covid-research-policy-and-economic-impact-session-ii/
LOCATION:Online
CATEGORIES:Long Covid,Webinar
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2022/03/Webinars.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220407T100000
DTEND;TZID=UTC:20220407T110000
DTSTAMP:20260802T090419
CREATED:20220303T053514Z
LAST-MODIFIED:20220309T210703Z
UID:33495-1649325600-1649329200@solvecfs.org
SUMMARY:ME/CFS: NO problem?
DESCRIPTION:Nitric oxide (NO) – a gas produced by cells lining the blood vessels (endothelial cells) – helps to promote the widening of blood vessels (vasodilation) and is involved in the immune and metabolic systems. This key process allows oxygenated blood to reach tissues throughout the body. The production of NO increases in response to physical activity in healthy individuals. However\, their findings in vitro suggest that ME/CFS patients might have a reduced ability to produce NO. \nOver the next few months\, Ramsay Researcher Dr. Francisco Westermeier and his team aim to expand the existing evidence by analyzing several biochemical pathways and metabolites responsible for NO production. \nIn this webinar\, Dr. Westermeier will discuss this Solve M.E.- supported project that uses samples from the UK ME/CFS Biobank. \nRegister here.
URL:https://solvecfs.org/event/me-cfs-no-problem/
LOCATION:Online
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2022/03/Add-a-heading.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220316T130000
DTEND;TZID=UTC:20220316T140000
DTSTAMP:20260802T090419
CREATED:20220310T165208Z
LAST-MODIFIED:20220310T165716Z
UID:33573-1647435600-1647439200@solvecfs.org
SUMMARY:Implications of ME/CFS Case Definitions for Long Covid
DESCRIPTION:Our friends at the U.S. Action Working Group are hosting Dr. Leonard Jason\, Professor of Psychology DePaul University\, for a special webinar event. \nLeonard Jason’s talk will cover the content below: \nEvery disease has a case definition\, and these entities are crucial\, as they allow patients to have a diagnosis for a constellation of symptoms as well as for scientists who can research those with the illness versus those without the illness. If difficulties occur in arriving at a reliable case definition\, there are serious consequences for patients\, as they would then be unsure whether or not they have the illness\, as well as for scientists\, who might then have difficulties in estimating prevalence as well as finding biomarkers. This has occurred for the post-viral illness that is known as ME/CFS and has already begun to occur for Long COVID. The consequences have been increased stigma for patients as to when patient heterogeneity makes it difficult to identify biomarkers\, and when they are not identified\, health care workers can easily attribute the condition to solely psychiatric reasons. The relevance of ME/CFS takes on even greater importance given recent findings that a PASC-anticipating risk factor at the time of initial COVID-19 diagnosis is the Epstein-Barr virus viremia\, which has also been associated with ME/CFS. \nRegister here.
URL:https://solvecfs.org/event/implications-of-me-cfs-case-definitions-for-long-covid/
LOCATION:Online
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2022/03/Jason2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220308T100000
DTEND;TZID=UTC:20220308T110000
DTSTAMP:20260802T090419
CREATED:20220222T234740Z
LAST-MODIFIED:20220301T021217Z
UID:33308-1646733600-1646737200@solvecfs.org
SUMMARY:Chronic Illnesses in Women: ME/CFS and Migraine
DESCRIPTION:Join us for this event in which ME/CFS & migraine comorbid communities collaborate to bring together patients\, researchers\, and doctors to discuss ME/CFS\, migraine disorders\, and their impact on women’s health. This webinar\, hosted by Solve M.E. and the Association for Migraine Disorders\, will feature presentations by Dr. James Baraniuk (Director of the Chronic Pain and Fatigue Research Center\, Georgetown University Medical Center)\, Dr. Nancy Klimas (Director\, Institute for Neuro-Immune Medicine)\, and community members Georgia Linders and Melinda Lipscomb. \nPlease join us March 8\, International Women’s Day\, at 10 am PT. 
URL:https://solvecfs.org/event/chronic-illnesses-in-women-me-cfs-and-migraine/
LOCATION:Online
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2022/02/TW-Migraine-ME_CFS-Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220218
DTEND;VALUE=DATE:20220219
DTSTAMP:20260802T090419
CREATED:20220120T190810Z
LAST-MODIFIED:20220120T191449Z
UID:32888-1645142400-1645228799@solvecfs.org
SUMMARY:National Caregivers Day
DESCRIPTION:National Caregivers Day honors people who provide personal\, physical\, and emotional care to members of our community. \nStay tuned for more information!
URL:https://solvecfs.org/event/national-caregivers-day/
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2022/01/National-Caregivers-Day.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220215T150000
DTEND;TZID=UTC:20220215T160000
DTSTAMP:20260802T090419
CREATED:20211209T174806Z
LAST-MODIFIED:20220107T001148Z
UID:31571-1644937200-1644940800@solvecfs.org
SUMMARY:Using Data Analysis to Study ME/CFS and Long Covid: Session 2
DESCRIPTION:We expanded our Ramsay Grant Program in 2021 by launching the new Stupski Awards\, which support research using data from the Registry. These webinars feature the 2021 Stupski Award recipients\, Efthymios Kalafatis and Jennifer Stone\, PhD\, who will discuss their research and answer your questions. \nJennifer Stone\, PhD\nAustralian National University \nDr. Stone will discuss her Stupski-supported project\, which uses advanced analytic methods to compare important demographic and clinical characteristics in people with ME/CFS to Long Covid controls and healthy controls. \nDr. Stone recently received her PhD in clinical epidemiology from Australian National University. She has co-authored several journal articles using data and modeling to uncover causes of disease. Jennifer earned her BA and MPH from the University of Queensland. \nSession II\nFebruary 15\, 2022\n3 pm PT\nPlease click here to register.
URL:https://solvecfs.org/event/using-data-analysis-to-study-me-cfs-and-long-covid-session-2/
LOCATION:Online
CATEGORIES:Long Covid,Webinar
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2021/12/revised.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220210T130000
DTEND;TZID=UTC:20220210T140000
DTSTAMP:20260802T090419
CREATED:20220112T171934Z
LAST-MODIFIED:20220112T171934Z
UID:32642-1644498000-1644501600@solvecfs.org
SUMMARY:Solve Spotlight: Writer Nadine Sander-Green in Conversation with Joe Komsky
DESCRIPTION:Before developing ME/CFS\, Canadian writer Nadine Sander-Green was an avid adventurer\, canoeing down rapids\, mountain-biking along rugged trails\, and skiing through waist-deep powder. Post-diagnosis\, she’s written in detail about her journey towards the acceptance of her new body and living within drastically smaller limits. \nIn this webinar\, Nadine talks to Solve M.E. Development Director Joe Komsky about her ME/CFS experience\, the impact of the disease on multiple family members\, and why the accurate and nuanced representation of people with ME/CFS in storytelling is so crucial to progress.
URL:https://solvecfs.org/event/solve-spotlight-writer-nadine-sander-green-in-conversation-with-joe-komsky/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2022/01/SanderGreenWebinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220210T120000
DTEND;TZID=UTC:20220210T130000
DTSTAMP:20260802T090419
CREATED:20220127T175259Z
LAST-MODIFIED:20220127T175259Z
UID:32994-1644494400-1644498000@solvecfs.org
SUMMARY:Long COVID & Fatiguing Illness Recovery Program ECHO
DESCRIPTION:(continuing on the 2nd Thursday of each month) \nNeurocognitive Manifestations of PASC \nMichelle Haddad\, PhD\nAssistant Professor\, Department of Rehabilitation Medicine Emory University School of Medicine \n  \n\n\n\nFamily Health Centers of San Diego\, the ECHO Institute\, University of Washington\, and University of Colorado have collaborated to provide a CDC-funded monthly webinar-style ECHO learning session to rapidly disseminate Post-acute Sequelae of SARS-COV-2 infection (PASC) and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) findings and emerging best practices. This large-scale national monthly ECHO webinar series will offer didactic presentations by subject matter experts\, examples of emerging best practices and models of care\, and a facilitated Q&A. This program is open to all healthcare professionals and all Long COVID and ME/CFS patient-lived experience experts interested in learning more about the treatment of Long COVID and ME/CFS.
URL:https://solvecfs.org/event/long-covid-fatiguing-illness-recovery-program-echo/
LOCATION:Online
CATEGORIES:Long Covid,Webinar
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2022/01/Untitled-design-7.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220209
DTEND;VALUE=DATE:20220212
DTSTAMP:20260802T090419
CREATED:20220119T204833Z
LAST-MODIFIED:20220119T204914Z
UID:32849-1644364800-1644623999@solvecfs.org
SUMMARY:Autoimmune Encephalopathy Secondary to Infectious Disease:  A New Perspective on the Pathogenetic Interaction of the Immune System\, Infection\, Stress and Chronic Disease
DESCRIPTION:From the conference website:\n“This landmark leadership conference is sponsored by Georgetown University and The Foundation for Total Recovery. Guest speakers from around the world will include distinguished specialists from Oxford\, Columbia\, Duke\, and even the leading medical center in the Middle East—Sheba Medical Center in Israel. Plan to join us\, as we have an exciting three days scheduled. This conference is a critical and long-overdue rethink of how we approach ME/CFS\, neuropsychiatric disorders\, PANS/PANDAS\, chronic Lyme\, fibromyalgia\, and even long-haul COVID-19. \nWe believe the treatment of these diseases needs to be viewed through a different lens—that of immune dysregulation resulting in neuroinflammation. We have to give up our belief that these are standalone diseases—especially if we want the best outcomes for patients. \nThis is a radical paradigm shift\, but we need it badly. We hope as practitioners\, patients\, and caregivers you will join us for this discussion as we discuss the future of diagnostic\, treatment\, and recovery for these patients.\nThe goals of this conference are three-fold: \nFirst\, we will explore the role of genetic and epigenetic factors that predispose an individual for immune dysregulation.  \nSecondly\, we will analyze the current evidence for infection-mediated immune dysregulation as it relates to Fibromyalgia\, ME/CFS\, neuropsychiatric illnesses\, Post-Lyme syndrome\, PANS/PANDAS\, and the post COVID-19 long haul syndrome (Long Covid).  \nThirdly\, we will examine current and new diagnostic testing procedures and treatment options for these conditions.”\n\nSolve M.E. will host a virtual booth at this event. Please stop by to say hello!
URL:https://solvecfs.org/event/autoimmune-encephalopathy-secondary-to-infectious-disease-a-new-perspective-on-the-pathogenetic-interaction-of-the-immune-system-infection-stress-and-chronic-disease/
CATEGORIES:Conference,Long Covid
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2022/01/unnamed-file.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220127T110000
DTEND;TZID=UTC:20220127T120000
DTSTAMP:20260802T090419
CREATED:20211227T221549Z
LAST-MODIFIED:20220125T182836Z
UID:31856-1643281200-1643284800@solvecfs.org
SUMMARY:Ampligen: A General Overview and the Plan for ME/CFS & Long Covid
DESCRIPTION:For the second installment in our clinical diagnostics and treatments webinar series\, Solve M.E. welcomes two leaders from bio-pharma company AIM ImmunoTech to discuss their plans for clinical studies of their investigational drug Ampligen\, in ME/CFS and Long Covid. In addition\, Drs. Lapp and Gottschalk will share insights from real-world use of Ampligen to treat patients with ME/CFS and Long Covid. \nAmpligen (Rintatolimod)\, is a drug that modulates the immune system and has anti-viral activity. It has been studied in clinical trials since the late 1980s\, and although it has been endorsed by countries outside the USA specifically for treating people with ME/CFS\, it does not have FDA approval. AIM has recently updated its plans for developing the drug in ME/CFS and Long Covid. \nThe application of Ampligen for both diseases is yet another example of how ME/CFS research can benefit people with ME/CFS and Long Covid\, and why the study of both is crucial to each community. \nJoin Solve President and CEO Oved Amitay in conversation with Thomas K. Equels\, M.S.\, J.D. (Chief Executive Officer\, AIM)\, and David R. Strayer\, M.D (Chief Scientific & Medical Officer\, AIM) to learn more about their plans for Ampligen and how the community may get involved. Dr. Charles Lapp (Medical Director\, Hunter-Hopkins Center) will discuss his use of Ampligen as a treatment for both ME/CFS and Long Covid\, and Dr. Gunnar Gottschalk (Executive Director/PI\, Simmaron Research Inc)\, will share data on the use of Ampligen in people with ME/CFS. \nRegister for the webinar here. \nDo you have a question for our panelists? Submit it to us at SolveCFS@solvecfs.org \nTo view the first webinar in our clinical diagnostics and treatments webinar series\, “Immune-Based Prediction of Long Covid and Implications for ME/CFS “ featuring Dr. Bruce Patterson\, click here.
URL:https://solvecfs.org/event/ampligen-a-general-overview-and-the-plan-for-me-cfs-long-covid/
LOCATION:Online
CATEGORIES:Long Covid,Webinar
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2021/12/Ampligen-FB-IG.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220121T110000
DTEND;TZID=UTC:20220121T130000
DTSTAMP:20260802T090419
CREATED:20220119T173516Z
LAST-MODIFIED:20220119T173516Z
UID:32827-1642762800-1642770000@solvecfs.org
SUMMARY:Understanding Long COVID Across Communities of Color\, Including Those Hardest Hit by COVID
DESCRIPTION:The National Institutes of Health (NIH) is hosting a listening session\, “Understanding Long COVID Across Communities of Color\, Including Those Hardest Hit by COVID” on Friday 1/21 from 2PM – 4PM EST. \n\n\nThe event will be hosted by the NIH RECOVER Initiative and the Initiative’s Clinical Science Core (CSC) at NYU Langone Health.This Listening Session is part of a series of ongoing engagement activities that enable the RECOVER Initiative to hear from and better understand affected communities’ experiences\, needs\, and priorities — and\, in this case\, specifically\, how Long COVID is affecting communities of color. Recognizing that communities of color are disproportionately affected by COVID-19\, it is likely that they similarly might experience a disproportionate burden of Long COVID. \n\nTune into this link the day of the event: https://videocast.nih.gov/ 
URL:https://solvecfs.org/event/understanding-long-covid-across-communities-of-color-including-those-hardest-hit-by-covid/
LOCATION:Online
CATEGORIES:Long Covid
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2022/01/Screen-Shot-2022-01-19-at-09.34.25.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220121T100000
DTEND;TZID=America/Los_Angeles:20220121T110000
DTSTAMP:20260802T090419
CREATED:20211130T142746Z
LAST-MODIFIED:20220107T001640Z
UID:22804-1642759200-1642762800@solvecfs.org
SUMMARY:Using Data Analysis to Study ME/CFS and Long Covid: Session 1
DESCRIPTION:We expanded our Ramsay Grant Program in 2021 by launching the new Stupski Awards\, which support research using data from the Registry. These webinars feature the 2021 Stupski Award recipients\, Efthymios Kalafatis and Jennifer Stone\, PhD\, who will discuss their research and answer your questions. \nEfthymios [Themos] Kalafatis\nData Scientist/Machine Learning Engineer \nKalafatis will discuss tracking his ME/CFS symptoms and analyzing the data and how that led to his Stupski-funded project\, which applies powerful machine learning and text analysis methods to better understand symptoms\, identify potential associations with treatments and life events and examine models of temporal patterns. \nKalafatis has over 20 years of data and text mining experience and holds a patent on a methodology that uses machine learning\, network analysis and natural language processing for medical research. He has applied artificial intelligence techniques to research ME/CFS and natural language processing methods to analyze patient records. Themos has a BA from the University of Portsmouth and a MSc from the University of East Anglia. \nSession I\nNEW DATE: January 21\, 2022\n10-11 am PT\nPlease click here to register.
URL:https://solvecfs.org/event/using-data-analysis-to-study-me-cfs-and-long-covid-session-1/
LOCATION:Online
CATEGORIES:Long Covid,Webinar
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2021/12/revised.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220119T090000
DTEND;TZID=UTC:20220119T100000
DTSTAMP:20260802T090419
CREATED:20220119T174555Z
LAST-MODIFIED:20220119T174555Z
UID:32833-1642582800-1642586400@solvecfs.org
SUMMARY:Long COVID Clubhouse: Patients meet Researchers with Consuli Conversations
DESCRIPTION:Long COVID Clubhouse: Patients meet Researchers with Consuli Conversations. Join us on #ClubhouseApp\n Wednesday\, 1/19\n 9:00 am PT\n We’ll be speaking to #doctors #researchers & #patients\n #longcovid #longhaulers #covidsymptoms\n Search for room: Long COVID: Patients meet Researchers
URL:https://solvecfs.org/event/long-covid-clubhouse-patients-meet-researchers-with-consuli-conversations/
LOCATION:Online
CATEGORIES:Long Covid
ATTACH;FMTTYPE=image/jpeg:https://solvecfs.org/wp-content/uploads/2022/01/consuli-.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211216T120000
DTEND;TZID=America/Los_Angeles:20211216T130000
DTSTAMP:20260802T090419
CREATED:20211130T154057Z
LAST-MODIFIED:20211130T154057Z
UID:22829-1639656000-1639659600@solvecfs.org
SUMMARY:CDC ME/CFS Stakeholder Engagement & Communication Conference Call
DESCRIPTION:The Centers for Disease Control (CDC) holds regular Stakeholder Engagement and Communication (SEC) calls to update the ME/CFS community on CDC activities and facilitate presentations from guest speakers. The next call on December 16 will feature updates from Elizabeth Unger\, PhD\, MD (Branch Chief\, Chronic Viral Diseases Branch\, Centers for Disease Control and Prevention) and the presentation “Is ME/CFS Another Face of Long Covid?” by Solve M.E. 2018 Ramsay Grant awardee Hector Bonilla\, MD (Clinical Associate Professor\, Medicine – Infectious Diseases\, Stanford University).
URL:https://solvecfs.org/event/cdc-me-cfs-stakeholder-engagement-communication-conference-call/
ATTACH;FMTTYPE=:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211215T090000
DTEND;TZID=America/Los_Angeles:20211215T100000
DTSTAMP:20260802T090419
CREATED:20211213T141506Z
LAST-MODIFIED:20220107T001511Z
UID:22899-1639558800-1639562400@solvecfs.org
SUMMARY:Emily Taylor Interview with WYPR's Midday
DESCRIPTION:Solve M.E. Vice President of Advocacy and Community Engagement Emily Taylor joins WYPR’s Midday host Tom Hall on Wednesday\, December 15\, from 12-1 pm ET / 9-10 am PT for a live radio conversation about our efforts to assist survivors with Long Covid and other post-infection chronic diseases. Also joining the conversation will be Long Covid Alliance member Chimére L. Smith.  \nListen to the interview here.
URL:https://solvecfs.org/event/emily-taylor-live-interview-with-wyprs-midday/
CATEGORIES:Long Covid,Media,Solve M.E. Leadership
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2018/03/emily-e1637691757648.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211206T110000
DTEND;TZID=America/Los_Angeles:20211206T120000
DTSTAMP:20260802T090419
CREATED:20211130T151838Z
LAST-MODIFIED:20220107T001420Z
UID:22819-1638788400-1638792000@solvecfs.org
SUMMARY:Immune-Based Prediction of Long Covid and Implications for ME/CFS
DESCRIPTION:Dr. Bruce Patterson is the CEO of IncellDx\, where he is developing a new paradigm for predicting\, identifying\, and treating people with Long Covid. \nDr. Patterson’s published scientific work suggests that Long Covid patients can be diagnosed reliably by analyzing patterns in cytokines- different types of proteins produced by a person’s immune system. Identifying a Long Covid immune system “fingerprint” may lead to a better understanding of the disease and to new treatment approaches that address the underlying causes. \nIn this webinar\, Dr. Patterson will describe his recent findings in COVID-19 and different pathogens that impair the immune system’s ability to function effectively\, and their implications for other diseases\, including ME/CFS. \nDr. Patterson made significant contributions to the diagnosis of HIV/AIDS and previously served as medical director of diagnostic virology at Stanford University School of Medicine.
URL:https://solvecfs.org/event/immune-based-prediction-of-long-covid-and-implications-for-me-cfs/
CATEGORIES:Long Covid,Webinar
ATTACH;FMTTYPE=:
END:VEVENT
END:VCALENDAR